Claimable_LogoWordmark_Primary.png
Claimable Launches Free Tool To Help PANS/PANDAS Patients Fight Unjust Denials and Secure IVIG Treatment
November 21, 2024 11:00 ET | Claimable
Claimable Launches Free Tool To Help PANS/PANDAS Patients Fight Unjust Denials and Secure IVIG Treatment.
Commure-logo_full-horizontal_black (8).png
Commure to Deploy Ambient AI Platform to Tenet Physician Resources for Enhanced Clinical Workflows
November 19, 2024 08:00 ET | Commure
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Commure, a leader in healthcare technology innovation, announced today that Tenet Healthcare Corporation (NYSE: THC), one of the nation’s...
PHA logo.png
Premier Health Announces Successful AI Deployment in Quebec
November 14, 2024 08:00 ET | Premier Health of America Inc.
Premier Health successfully deployed AI and achieved a 89% precision rate in interpreting client data, gaining 25% operational efficiency.
greylogo.png
VitalHub Announces Q3 2024 Conference Call Date
November 04, 2024 09:00 ET | VitalHub Corp.
TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it will release its financial results for its third...
PHA logo.png
Premier Health Announces Notice of Award for Independent Labour for the Outaouais Region in Quebec
October 24, 2024 09:02 ET | Premier Health of America Inc.
MONTRÉAL, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian health tech company, announces that it was...
Smart Immune détermi
Smart Immune détermine la dose recommandée de SMART101 pour ses essais cliniques en oncologie
October 23, 2024 01:01 ET | Smart Immune
La phase I d'escalade de dose de ReSET-02 chez des adultes souffrant de cancers hématologiques est terminée.Le segment randomisé de la phase II de cet essai est en cours.Aucune toxicité limitant la...
SMART IMM_LOGO 2023_RVB.png
Smart Immune Announces Recommended SMART101 Dose for Adult Cancer Proof-of-Concept Trials
October 23, 2024 01:01 ET | Smart Immune
ReSET-02 dose escalation Phase I is completedPhase II PoC randomized segment is starting No dose-limiting toxicities, no safety or tolerability issuesThe highest dose is to be used in both...
OshiLeftTM_RGB 2.jpg
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
October 16, 2024 08:00 ET | Oshi Health
Oshi Health Raises $60M Series C to Strengthen Its Position as the Category Leader for Virtual Digestive Care
PHA logo.png
Premier Health Announces Notice of Award for Independent Labour for Nordic Customers in Quebec
October 09, 2024 15:43 ET | Premier Health of America Inc.
MONTRÉAL, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian healthtech company, announces that it was...
Huma_Logo_Grey (1) (2).png
Huma acquires eConsult and launches Huma Workspace for Health systems
October 04, 2024 13:10 ET | Huma
London, UK , Oct. 04, 2024 (GLOBE NEWSWIRE) -- Huma, a global leader in healthcare AI and digital health solutions, is pleased to announce its acquisition of eConsult, one of the largest...